# MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ

> **NCT00586326** · PHASE2 · COMPLETED · sponsor: **Hologic, Inc.** · enrollment: 133 (actual)

## Conditions studied

- DCIS

## Interventions

- **DEVICE:** MammoSite Radiation Therapy System

## Key facts

- **NCT ID:** NCT00586326
- **Lead sponsor:** Hologic, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2006-01
- **Final completion:** 2011-04
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2012-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00586326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00586326, "MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00586326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*